CS logo
small CS logo
Pardubicka krajska nemocnice a.s.

Pardubice, Czechia
Hospital
Kyjevská 44, 530 03 Pardubice IV

About Pardubicka krajska nemocnice a.s.


"Pardubická nemocnice je součástí společnosti Nemocnice Pardubického kraje, a. s. Ta se s ročním obratem více než 3,5 miliardy korun a zhruba 4 600 zaměstnanci řadí mezi desítku největších nemocnic v zemi. Společnost tvoří pět pracovišť: • Pardubická nemocnice • Chrudimská nemocnice • Orlickoústecká nemocnice • Litomyšlská nemocnice • Svitavská nemocnice"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Pardubicka krajska nemocnice a.s.


During the past decade, Pardubicka krajska nemocnice a.s. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Pardubicka krajska nemocnice a.s." #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Ipsen" with 2 trials sponsored, "AbbVie" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Agennix" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pardubicka krajska nemocnice a.s." #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "IQVIA, formerly Quintiles" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Vaccibody AS" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Pardubicka krajska nemocnice a.s.


According to Clinical.Site data, the most researched conditions in "Pardubicka krajska nemocnice a.s." are "Ulcerative Colitis" (4 trials), "Multiple Sclerosis" (2 trials), "Acute Coronary Syndrome" (1 trials), "Advanced Parkinson's Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Pardubicka krajska nemocnice a.s." in a lesser frequency.

Clinical Trials Intervention Types at Pardubicka krajska nemocnice a.s.


Most popular intervention types in "Pardubicka krajska nemocnice a.s." are "Drug" (18 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (3 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Pardubicka krajska nemocnice a.s.


The vast majority of trials in "Pardubicka krajska nemocnice a.s." are 20 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Pardubicka krajska nemocnice a.s.


Currently, there are NaN active trials in "Pardubicka krajska nemocnice a.s.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Pardubicka krajska nemocnice a.s., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Pardubicka krajska nemocnice a.s., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".